Zurcher Kantonalbank »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Zurcher Kantonalbank

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Zurcher Kantonalbank from 13F filings

Historical chart of Zurcher Kantonalbank investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Zurcher Kantonalbank consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Zurcher Kantonalbank

Quarter filed Position value Share count Share price at filing
2024-09-30 $585k 500k 1.17
2024-06-30 $556k 500k 1.11
2024-03-31 $486k 500k 0.97
2023-12-31 $465k 500k 0.93
2023-09-30 $930k 1.0M 0.93

More positions owned by Zurcher Kantonalbank

Apple (AAPL)
Ubs Group SHS (UBS)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Alcon Ord Shs (ALC)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Eli Lilly & Co. (LLY)
UnitedHealth (UNH)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Visa Com Cl A (V)
JPMorgan Chase & Co. (JPM)

View all positions for Zurcher Kantonalbank

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

M&G
Citadel Advisors
MacKay Shields
Lazard Asset Management
Calamos Advisors
Polar Securities
BlackRock
Wolverine Asset Management
Ing Investment Management
Wells Fargo & Company
CNH Partners
State Street Corporation
BlackRock
Absolute Investment Advisers
Glazer Capital

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1